Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune vestibulo-cochlear disorders.

M U Rahman1, D S Poe, H K Choi

  • 1Rheumatology Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA. mrahman@partners.org

Current Opinion in Rheumatology
|May 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115: 2526-2532, 2007.

Clinical journal of the American Society of Nephrology : CJASN·2023
Same author

Efficacy of pentamidine-loaded chitosan nanoparticles as a novel drug delivery system for Leishmania tropica.

Tropical biomedicine·2023
Same author

Proton pump inhibitor therapy and risk of knee replacement surgery: a general population-based cohort study.

Osteoarthritis and cartilage·2022
Same author

Timing of antibiotics in septic patients: a prospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

The incidence and seasonal variation of necrotizing fasciitis in Korea: a nationwide cross-sectional study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Association of tramadol with risk of myocardial infarction among patients with osteoarthritis.

Osteoarthritis and cartilage·2019
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Autoimmune vestibulo-cochlear disorders (AVCD) cause hearing loss and vertigo. Prompt treatment with immunosuppressants may preserve function, though evidence is limited.

Area of Science:

  • Otolaryngology
  • Rheumatology
  • Immunology

Background:

  • Autoimmune vestibulo-cochlear disorders (AVCD) present with sensorineural hearing loss, vertigo, tinnitus, and aural fullness.
  • Pathogenesis is presumed autoimmune, though direct evidence remains elusive.
  • Rapidly progressive AVCD mirrors rapidly progressive glomerulonephritis, necessitating urgent intervention.

Purpose of the Study:

  • To review therapies for AVCD.
  • To present experience with etanercept in AVCD.

Main Methods:

  • Review of reported therapies for AVCD.
  • Clinical experience with etanercept in AVCD patients.

Main Results:

  • Corticosteroids and immunosuppressive agents can preserve hearing and vestibular function.

Related Experiment Videos

  • No randomized controlled trials currently exist for AVCD therapies.
  • Etanercept therapy outcomes in AVCD are presented.

    • Conclusions:

    • Prompt treatment of AVCD with immunosuppressants is crucial for function preservation.
    • Further research, including randomized controlled trials, is needed to establish optimal AVCD therapies.
    • Etanercept shows potential as a therapeutic option for AVCD.